Clinical Trial Update: Bioavailability of LY03004 and Risperdal® Consta® [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the bioavailability of LY03004 relative to Risperdal Consta (paliperidone palmitate) has been completed. The trial targets patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• LY03004
• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED